217 related articles for article (PubMed ID: 8128091)
1. [The kinetics of IL-2 after pleural administration in the treatment of neoplastic pleurisy].
Astoul P; Bertault-Peres P; Durand A; Boutin C
Rev Mal Respir; 1994; 11(1):29-35. PubMed ID: 8128091
[TBL] [Abstract][Full Text] [Related]
2. Intrapleural recombinant IL-2 in passive immunotherapy for malignant pleural effusion.
Astoul P; Viallat JR; Laurent JC; Brandely M; Boutin C
Chest; 1993 Jan; 103(1):209-13. PubMed ID: 8417880
[TBL] [Abstract][Full Text] [Related]
3. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
Lucchi M; Chella A; Melfi F; Dini P; Ambrogi M; Fino L; Fontanini G; Mussi A
Eur J Cardiothorac Surg; 2007 Mar; 31(3):529-33; discussion 533-4. PubMed ID: 17188885
[TBL] [Abstract][Full Text] [Related]
4. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma.
Lu C; Perez-Soler R; Piperdi B; Walsh GL; Swisher SG; Smythe WR; Shin HJ; Ro JY; Feng L; Truong M; Yalamanchili A; Lopez-Berestein G; Hong WK; Khokhar AR; Shin DM
J Clin Oncol; 2005 May; 23(15):3495-501. PubMed ID: 15908659
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of mesothelioma with interferon gamma and interleukin 2].
Boutin C; Viallat JR; Astoul P
Rev Pneumol Clin; 1990; 46(5):211-5. PubMed ID: 2127468
[TBL] [Abstract][Full Text] [Related]
7. [Thoracoscopy in pleural mesothelioma].
Zhang DH; Gu YT; Pan WS
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Jun; 16(3):150-3, 187. PubMed ID: 8242812
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma.
Eton O; Rosenblum MG; Legha SS; Zhang W; Jo East M; Bedikian A; Papadopoulos N; Buzaid A; Benjamin RS
Cancer; 2002 Jul; 95(1):127-34. PubMed ID: 12115326
[TBL] [Abstract][Full Text] [Related]
9. [Intrapleural talc in malignant pleural effusions (author's transl)].
Scarbonchi J; Boutin C; Cargnino P; Scarbonchi-Efimieff T
Poumon Coeur; 1981; 37(5):283-9. PubMed ID: 7312760
[TBL] [Abstract][Full Text] [Related]
10. Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study.
Goey SH; Eggermont AM; Punt CJ; Slingerland R; Gratama JW; Oosterom R; Oskam R; Bolhuis RL; Stoter G
Br J Cancer; 1995 Nov; 72(5):1283-8. PubMed ID: 7577483
[TBL] [Abstract][Full Text] [Related]
11. [Clinical treatment with cisplatin (CDDP) in pleural cavity for carcinomatous pleurisy--study of intraarterial concentration].
Hara S; Tagawa Y; Tsuji H; Oka T; Morinaga M; Shingu H; Nagayasu T; Ikuta Y; Ayabe H
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1509-11. PubMed ID: 8854792
[TBL] [Abstract][Full Text] [Related]
12. Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients.
Castagneto B; Zai S; Mutti L; Lazzaro A; Ridolfi R; Piccolini E; Ardizzoni A; Fumagalli L; Valsuani G; Botta M
Lung Cancer; 2001; 31(2-3):303-10. PubMed ID: 11165411
[TBL] [Abstract][Full Text] [Related]
13. Intrapleural immunotherapy with escalating doses of interleukin-2 in metastatic pleural effusions.
Viallat JR; Boutin C; Rey F; Astoul P; Farisse P; Brandely M
Cancer; 1993 Jun; 71(12):4067-71. PubMed ID: 8508372
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of intrapleural recombinant interleukin-2 in immunotherapy for malignant pleural effusion.
Astoul P; Bertault-Peres P; Durand A; Catalin J; Vignal F; Boutin C
Cancer; 1994 Jan; 73(2):308-13. PubMed ID: 8293393
[TBL] [Abstract][Full Text] [Related]
15. Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer.
Yasumoto K; Mivazaki K; Nagashima A; Ishida T; Kuda T; Yano T; Sugimachi K; Nomoto K
Cancer Res; 1987 Apr; 47(8):2184-7. PubMed ID: 3493843
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics and pleural reaction of doxycycline after intrapleural administration].
Homma T; Yoneda S; Komuro Y; Yoshida S; Min KY; Takayama S
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1129-34. PubMed ID: 6870294
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic and therapeutic thoracoscopy in 83 cases of chronic pleurisy].
Ladjimi S; Djemel A; Ben Youssef R; Ben Ayed F; Jaziri M; Belhassen S; Kammoun M; Zegaya M; Mourali N
Rev Mal Respir; 1985; 2(6):355-9. PubMed ID: 3835612
[TBL] [Abstract][Full Text] [Related]
18. Pathology of the pleura: what the pulmonologists need to know.
Cagle PT; Allen TC
Respirology; 2011 Apr; 16(3):430-8. PubMed ID: 21362105
[TBL] [Abstract][Full Text] [Related]
19. Bolus high dose interleukin-2 for the treatment of malignant melanoma.
Pappo I; Lotem M; Klein M; Orda R
Isr Med Assoc J; 2001 Mar; 3(3):169-73. PubMed ID: 11303372
[TBL] [Abstract][Full Text] [Related]
20. [Pathology of the pleura].
Boutin C
Rev Prat; 1990 Sep; 40(20):1821-2. PubMed ID: 2218344
[No Abstract] [Full Text] [Related]
[Next] [New Search]
